
PTC Therapeutics granted 3,825 stock options and 4,385 RSUs on Dec. 16, 2025.
In Warren, New Jersey, on December 19, 2025, PTC Therapeutics, Inc. shared that it granted non-statutory stock options allowing the purchase of a total of 3,825 shares of its common stock alongside 4,385 restricted stock units ("RSUs") on December 16, 2025. The company's ticker symbol on the NASDAQ is PTCT, and this decision marks a notable development in their stock-based compensation plans.

